Zoetis Releases 2024 Sustainability Progress Update
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zoetis Inc (ZTS)
Zoetis Inc stock price live, this page displays NYSE ZTS stock exchange data. View the ZTS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zoetis Inc real time stock price chart below.
What Is the Zoetis Inc Stock Price Today?
The Zoetis Inc stock price today is 164.33.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the NYSE stock exchange.
Is Zoetis Inc a Good Stock to Buy?
Determining whether Zoetis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZTS quote. (ISIN: US98978V1035)
What Is the Zoetis Inc Stock Price Today?
The Zoetis Inc stock price today is 164.33.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the NYSE stock exchange.
Is Zoetis Inc a Good Stock to Buy?
Determining whether Zoetis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZTS quote. (ISIN: US98978V1035)
164.33
-4.49(-2.66%)
Closed·
After Hours
164.55+0.22(+0.13%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
163.51
167.38
52 wk Range
139.70
200.33
ZTS Scorecard
Full Analysis
Management has been aggressively buying back shares
ZTS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
163.51167.38
52 wk Range
139.70200.33
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZTS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
195.37
Upside
+18.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 12 consecutive years
- Zoetis Declares Third Quarter 2025 Dividend
- Investing.com
- Zoetis Releases 2024 Sustainability Progress Update
- Investing.com
- Zoetis appoints UC Davis Dean to Board of Directors
- Investing.com
Zoetis Inc Company Profile
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1950 and is headquartered in Parsippany, New Jersey.
Zoetis Inc SWOT Analysis
Market Leadership | Zoetis maintains dominance in animal health, with a robust portfolio spanning companion animal and livestock sectors, despite increasing competition |
Financial Resilience | Analysts project continued growth, with Q3 2024 organic revenue expected to rise 9.2%. Price targets range from $225 to $242, reflecting positive outlook |
Product Innovation | Explore Zoetis's key growth drivers, including Librela for canine osteoarthritis and Apoquel for dermatology, alongside a promising pipeline in oncology and cardiology |
Future Prospects | Delve into Zoetis's strategies for tapping untapped markets in animal anti-depressants and pain management, while navigating challenges like foreign exchange impacts |
Zoetis Inc Earnings Call Summary for Q1/2025
- Zoetis surpassed Q1 2025 expectations with EPS of $1.48 and revenue of $2.22B, showing 9% organic operational growth
- Despite strong results, stock fell 4.64% to $150.73, reflecting potential investor concerns or broader market influences
- Full-year guidance: revenue $9.425-9.575B, organic growth 6-8%, adjusted EPS $6.20-6.30
- Key product lines like Simparica and OA pain monoclonal antibodies showed significant growth
- Executives highlighted industry resilience but noted regulatory and competitive challenges ahead
Last Updated: 07/05/2025, 12:08 am
Read Full TranscriptCompare ZTS to Peers and Sector
Metrics to compare | ZTS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZTSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 29.1x | −1.5x | −0.5x | |
PEG Ratio | 3.97 | 0.00 | 0.00 | |
Price/Book | 15.7x | 0.8x | 2.6x | |
Price / LTM Sales | 7.9x | 0.7x | 3.1x | |
Upside (Analyst Target) | 21.7% | 27.5% | 50.4% | |
Fair Value Upside | Unlock | 23.2% | 8.7% | Unlock |
Analyst Ratings
14 Buy
5 Hold
0 Sell
Ratings:
19 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 195.37
(+18.89% Upside)
Earnings
Latest Release
May 06, 2025
EPS / Forecast
1.48 / 1.41
Revenue / Forecast
2.22B / 2.20B
People Also Watch
FAQ
What Is the Zoetis Inc (ZTS) Stock Price Today?
The Zoetis Inc stock price today is 164.33
What Stock Exchange Does Zoetis Inc Trade On?
Zoetis Inc is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Zoetis Inc?
The stock symbol for Zoetis Inc is "ZTS."
Does Zoetis Inc Pay Dividends? What’s The Current Dividend Yield?
The Zoetis Inc dividend yield is 1.22%.
What Is the Zoetis Inc Market Cap?
As of today, Zoetis Inc market cap is 73.16B.
What Is Zoetis Inc's Earnings Per Share (TTM)?
The Zoetis Inc EPS (TTM) is 5.58.
When Is the Next Zoetis Inc Earnings Date?
Zoetis Inc will release its next earnings report on 11 Aug 2025.
From a Technical Analysis Perspective, Is ZTS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Zoetis Inc Stock Split?
Zoetis Inc has split 0 times.
How Many Employees Does Zoetis Inc Have?
Zoetis Inc has 13800 employees.
What is the current trading status of Zoetis Inc (ZTS)?
As of 14 June 2025, Zoetis Inc (ZTS) is trading at a price of 164.33, with a previous close of 168.82. The stock has fluctuated within a day range of 163.51 to 167.38, while its 52-week range spans from 139.70 to 200.33.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.